Department of Tissue Engineering and Regenerative Medicine

OUR SUCCESS STORIES

DTERM is taking proactive measure in making sure high quality services are given to students and customer. Discover more on DTERM success through the stories here. 

PUBLICATIONS STATS

2025 (25/40) PUBLISHED ARTICLE

62.5%

2024 (44/32 PUBLISHED ARTICLE)

100%

2023 (51/36 PUBLISHED ARTICLE)

100%

2022 (44/36 PUBLISHED ARTICLE)

100%

2021 (44/32 PUBLISHED ARTICLE)

100%

2020 (39/32 PUBLISHED ARTICLE

100%

OUR PRODUCTS

CLINICAL TRANSLATIONAL PHASE

MyDerm

Completed phase I/IIa in 2016

ColPatch

 3D tissue-engineered skin substitute

Dermal Fibroblast Sera

For skin rejuvenation

Skin Cell Drop

Autologous skin cells with PRP for wound healing

FUTURE CLINICAL TRANSLATIONAL 

LututKu

For treatment of osteoarthritis

Bone Construct

Using TCP/HA scaffold for bone regeneration

3D-bioprinted Bioink & Biomaterial Ink

For wound healing

error: Content is protected !!